Bristol-Myers to Take a $3B Tax Hit in Q4 2017 Post author:Sam Post published:January 7, 2018 Post category:BioPharma The expense is primarily related to taxes on unremitted offshore earnings, the company said. Source: BioSpace You Might Also Like Pfizer Strikes Deal With Array BioPharma on Anti-Cancer Development December 18, 2017 Merck Laying Off 50 Employees in North Carolina December 10, 2017 Bay Area's Portola Rockets as the FDA Approves First and Only Anticoagulant for Hospitals June 25, 2017
Bay Area's Portola Rockets as the FDA Approves First and Only Anticoagulant for Hospitals June 25, 2017